首页> 外国专利> Cytopathic replication of hepatitis C virus in a new cell line

Cytopathic replication of hepatitis C virus in a new cell line

机译:丙型肝炎病毒在新细胞系中的细胞病变复制

摘要

We have cloned human lymphoid cell lines that are susceptible to hepatitis C virus (HCV) infection, and in which infection with HCV results in the development of cytopathic effects, including cell degeneration, induction of cell syncytia and cell death, as well as in the production of progeny virus. Infection was confirmed by the polymerase chain reaction, indirect immunofluorescence of viral antigens, and detection of the viral RNA-dependent RNA polymerase. Progeny virus released from the infected cells into the medium could be serially passaged using the cell-free supernatant fluid as the inoculum. Also described are uses of the cloned cell lines for both intact cell and cell- free assay systems for the effectiveness of candidate anti-HCV drugs.
机译:我们已经克隆了易受丙型肝炎病毒(HCV)感染的人类淋巴样细胞系,其中感染HCV会导致细胞病变的发展,包括细胞变性,细胞合胞体诱导和细胞死亡,以及子代病毒的产生。通过聚合酶链反应,病毒抗原的间接免疫荧光和病毒RNA依赖性RNA聚合酶的检测证实了感染。从感染细胞释放到培养基中的子代病毒可以使用无细胞上清液作为接种物连续传代。还描述了克隆细胞系在完整细胞和无细胞测定系统中的用途,以用于候选抗HCV药物的有效性。

著录项

  • 公开/公告号US5851758A

    专利类型

  • 公开/公告日1998-12-22

    原文格式PDF

  • 申请/专利权人 CHILDRENS RESEARCH INSTITUTE;

    申请/专利号US19950547842

  • 发明设计人 ROBERTO P. FERNANDEZ-LARSSON;

    申请日1995-10-25

  • 分类号C12Q1/70;G01N33/53;C12N5/22;A61K39/42;

  • 国家 US

  • 入库时间 2022-08-22 02:09:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号